The estimated prevalence of clinically significant cryoglobulinemia is 1 in 100,000.[6]Silva F, Pinto C, Barbosa A, et al. New insights in cryoglobulinemic vasculitis. J Autoimmun. 2019 Dec;105:102313.
http://www.ncbi.nlm.nih.gov/pubmed/31383568?tool=bestpractice.com
Mixed cryoglobulinemia (MC) is the most common type, and it is strongly associated with chronic hepatitis C virus (HCV) infection.[6]Silva F, Pinto C, Barbosa A, et al. New insights in cryoglobulinemic vasculitis. J Autoimmun. 2019 Dec;105:102313.
http://www.ncbi.nlm.nih.gov/pubmed/31383568?tool=bestpractice.com
[7]Roccatello D, Saadoun D, Ramos-Casals M, et al. Cryoglobulinaemia. Nat Rev Dis Primers. 2018 Aug 2;4(1):11.
http://www.ncbi.nlm.nih.gov/pubmed/30072738?tool=bestpractice.com
The estimated prevalence of MC is <5 cases per 10,000 individuals in Europe and North America.[7]Roccatello D, Saadoun D, Ramos-Casals M, et al. Cryoglobulinaemia. Nat Rev Dis Primers. 2018 Aug 2;4(1):11.
http://www.ncbi.nlm.nih.gov/pubmed/30072738?tool=bestpractice.com
Higher prevalence is reported in some areas, such as the Mediterranean.[8]Monti G, Saccardo F, Castelnovo L, et al. Prevalence of mixed cryoglobulinaemia syndrome and circulating cryoglobulins in a population-based survey: the origgio study. Autoimmun Rev. 2014 Jun;13(6):609-14.
http://www.ncbi.nlm.nih.gov/pubmed/24418294?tool=bestpractice.com
Cryoglobulins may be detected in up to 50% of patients with HCV infection, but only a small proportion may develop a cryoglobulinemic syndrome.[6]Silva F, Pinto C, Barbosa A, et al. New insights in cryoglobulinemic vasculitis. J Autoimmun. 2019 Dec;105:102313.
http://www.ncbi.nlm.nih.gov/pubmed/31383568?tool=bestpractice.com
Type I cryoglobulinemia accounts for 5% to 25% of cases.[6]Silva F, Pinto C, Barbosa A, et al. New insights in cryoglobulinemic vasculitis. J Autoimmun. 2019 Dec;105:102313.
http://www.ncbi.nlm.nih.gov/pubmed/31383568?tool=bestpractice.com